Psoriasis therapies targeted

Washington - Findings of a retrospective analysis designed to characterize comorbidities in the psoriasis population and adverse events associated with systemic therapies will hopefully increase physician understanding of their psoriasis patients and thereby enhance patient care, said Daniel J. Pearce, M.D., at the annual meeting of the American Academy of Dermatology.

Related Videos
© 2023 MJH Life Sciences

All rights reserved.